Key points are not available for this paper at this time.
You have accessJournal of UrologyProstate Cancer: Epidemiology from year 1-9, individuals at risk is shown. The Cross validated RCT showed the prediction of progression based on significant factors: PSAD; MRI prostate volume(preMRIPV). After five years, 87% of individuals were free from progression, and 8% DOC. CONCLUSIONS: Office-based MRFC is showing a noteworthy impact on the natural progression of prostate cancer. However, it is essential to verify these results by conducting a comprehensive assessment of randomized controlled trials. Download PPT Source of Funding: Urologic Research Network Foundation © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e622 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Fernando J. Bianco More articles by this author Giuseppe Maiolino More articles by this author Edward L. Gheiler More articles by this author Ariel M. Kaufman More articles by this author Juan I. Martinez-Salamanca More articles by this author Farshad Shafizadeh More articles by this author Gloria Egui-Benatuil More articles by this author Michael Kattan More articles by this author Expand All Advertisement PDF downloadLoading ...
Bianco et al. (Mon,) studied this question.